Tumor infiltrating lymphocytes predict benefit from TAC but not from ddAC in triple negative breast cancer in the randomized MATADOR trial (BOOG 2004-04) A.G.J. van Rossum, M. Hoogstraat,M. Opdam,H. Horlings,L. Wessels,R.M. Kerkhoven,A.E. van Leeuwen - Stok, H.M. Oosterkamp,M. Kok,S.C. LinnANNALS OF ONCOLOGY（2018）引用 2|浏览49暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
